The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-5-((5-(4-(Dimethylamino)phenyl)pyridin-3-yl)methylene)-2-iminothiazolidin-4-one ID: ALA4538609
PubChem CID: 155549000
Max Phase: Preclinical
Molecular Formula: C17H16N4OS
Molecular Weight: 324.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)c1ccc(-c2cncc(/C=C3\SC(=N)NC3=O)c2)cc1
Standard InChI: InChI=1S/C17H16N4OS/c1-21(2)14-5-3-12(4-6-14)13-7-11(9-19-10-13)8-15-16(22)20-17(18)23-15/h3-10H,1-2H3,(H2,18,20,22)/b15-8-
Standard InChI Key: MFZLMACKJGFEJM-NVNXTCNLSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
4.5922 -3.4916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5910 -4.3111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2991 -4.7201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0088 -4.3107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0059 -3.4880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2973 -3.0827 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8830 -4.7192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1756 -4.3100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0938 -3.4944 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.2946 -3.3238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8854 -4.0313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4318 -4.6389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9628 -2.5770 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2606 -5.4380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7171 -4.7181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7135 -5.5357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4210 -5.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1291 -5.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1252 -4.7119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4171 -4.3082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8380 -5.9399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8404 -6.7571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5445 -5.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 8 1 0
10 13 2 0
12 14 2 0
4 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
21 22 1 0
21 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 324.41Molecular Weight (Monoisotopic): 324.1045AlogP: 2.95#Rotatable Bonds: 3Polar Surface Area: 69.08Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.86CX Basic pKa: 4.83CX LogP: 2.40CX LogD: 2.40Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.85Np Likeness Score: -1.48
References 1. Manz TD, Sivakumaren SC, Ferguson FM, Zhang T, Yasgar A, Seo HS, Ficarro SB, Card JD, Shim H, Miduturu CV, Simeonov A, Shen M, Marto JA, Dhe-Paganon S, Hall MD, Cantley LC, Gray NS.. (2020) Discovery and Structure-Activity Relationship Study of (Z)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors., 63 (9): [PMID:32298120 ] [10.1021/acs.jmedchem.0c00227 ]